NDRG1 contributes to tumor aggressiveness by cell proliferation and lipid metabolism regulation [75,76], whereas GAPVD1 [77], INPP5A [78], TCN1 [79], SAV1 [80], RBBP8 [81], SPIB [82], and UBE2A [83] also exhibit oncogenic or tumor-suppressive properties associated with prognosis. Here, GAPVD1 is linked to neoplasm.